BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 26896032)

  • 1. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
    Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J
    J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Value of a Seven-Autoantibody Panel Combined with the Mayo Model in the Differential Diagnosis of Pulmonary Nodules.
    Ling Z; Chen J; Wen Z; Wei X; Su R; Tang Z; Hu Z
    Dis Markers; 2021; 2021():6677823. PubMed ID: 33688380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules.
    Lastwika KJ; Kargl J; Zhang Y; Zhu X; Lo E; Shelley D; Ladd JJ; Wu W; Kinahan P; Pipavath SNJ; Randolph TW; Shipley M; Lampe PD; Houghton AM
    Am J Respir Crit Care Med; 2019 May; 199(10):1257-1266. PubMed ID: 30422669
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
    Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q
    Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
    Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
    J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
    Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
    Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case study of an autoantibody panel for early detection of lung cancer and ground-glass nodules.
    Huo Y; Guo Z; Gao X; Liu Z; Zhang R; Qin X
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3349-3357. PubMed ID: 32648227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early diagnosis of subtype in early clinical stage lung adenocarcinoma by using an autoantibody panel and computed tomography].
    Meng QC; Gao PR; Ren PF; Song YP; Li HL
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(3):204-208. PubMed ID: 30669764
    [No Abstract]   [Full Text] [Related]  

  • 9. A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT.
    Kossenkov AV; Qureshi R; Dawany NB; Wickramasinghe J; Liu Q; Majumdar RS; Chang C; Widura S; Kumar T; Horng WH; Konnisto E; Criner G; Tsay JJ; Pass H; Yendamuri S; Vachani A; Bauer T; Nam B; Rom WN; Showe MK; Showe LC
    Cancer Res; 2019 Jan; 79(1):263-273. PubMed ID: 30487137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma.
    Li Y; Li CQ; Guo SJ; Guo W; Jiang HW; Li HC; Tao SC
    EBioMedicine; 2020 Mar; 53():102674. PubMed ID: 32113159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of autoantibody responses against tumor-associated antigens in thyroid cancer.
    Abols A; Ducena K; Zayakin P; Silina K; Kalnina Z; Sadovska L; Tars J; Vilmanis J; Narbuts Z; Eglitis J; Pirags V; Line A
    Cancer Biomark; 2014; 14(5):361-9. PubMed ID: 25171478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer.
    Djureinovic D; Dodig-Crnković T; Hellström C; Holgersson G; Bergqvist M; Mattsson JSM; Pontén F; Ståhle E; Schwenk JM; Micke P
    Lung Cancer; 2018 Nov; 125():157-163. PubMed ID: 30429015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of lung cancer by using an autoantibody panel in Chinese population.
    Ren S; Zhang S; Jiang T; He Y; Ma Z; Cai H; Xu X; Li Y; Cai W; Zhou J; Liu X; Hu X; Zhang J; Yu H; Zhou C; Hirsch FR
    Oncoimmunology; 2018; 7(2):e1384108. PubMed ID: 29308305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
    Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
    Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Proteomic Features To Distinguish Benign Pulmonary Nodules from Lung Adenocarcinoma.
    Codreanu SG; Hoeksema MD; Slebos RJC; Zimmerman LJ; Rahman SMJ; Li M; Chen SC; Chen H; Eisenberg R; Liebler DC; Massion PP
    J Proteome Res; 2017 Sep; 16(9):3266-3276. PubMed ID: 28731711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?
    Liu L; Liu N; Liu B; Yang Y; Zhang Q; Zhang W; Yu P; Jin Y; Guo J; Guan S; Sun S; Miao L; Wei J
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1737-42. PubMed ID: 22699933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies.
    Broodman I; Lindemans J; van Sten J; Bischoff R; Luider T
    J Proteome Res; 2017 Jan; 16(1):3-13. PubMed ID: 27769114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
    Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
    J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of tumor-associated antigens and autoantibody panel combination detection in the early diagnostic of lung cancer.
    Ouyang R; Wu S; Zhang B; Wang T; Yin B; Huang J; Wei W; Huang M; Zhang M; Wang Y; Wang F; Hou H
    Cancer Biomark; 2021; 32(3):401-409. PubMed ID: 34151844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma.
    Chen G; Wang X; Yu J; Varambally S; Yu J; Thomas DG; Lin MY; Vishnu P; Wang Z; Wang R; Fielhauer J; Ghosh D; Giordano TJ; Giacherio D; Chang AC; Orringer MB; El-Hefnawy T; Bigbee WL; Beer DG; Chinnaiyan AM
    Cancer Res; 2007 Apr; 67(7):3461-7. PubMed ID: 17409457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.